The role of oestrogens for breast cancer growth is evidenced by the success of anti-hormonal treatment regimens, e.g. selective estrogen receptor modulators such as tamoxifen, in improving clinical outcome in the disease. The gene discussed is ESR1; the disease is breast cancer.